Return to: Aspartame ( NutraSweet ) Toxicity Information Center Main Page.

Analysis Shows Nearly 100% of Independent Research Finds Problems With Aspartame

October 17, 1996

An analysis of peer reviewed medical literature using MEDLINE and other databases was conducted by Ralph G. Walton, MD, Chairman, The Center for Behavioral Medicine, Professor of Clinical Psychiatry, Northeastern Ohio Universities College of Medicine. Dr. Walton analyzed 164 studies which were felt to have relevance to human safety questions. Of those studies, 74 studies had aspartame industry-related sponsorship and 90 were funded without any industry money.

Of the 90 non-industry-sponsored studies, 83 (92%) identified one or more problems with aspartame. Of the 7 studies which did not find a problems, 6 of those studies were conducted by the FDA. Given that a number of FDA officials went to work for the aspartame industry immediately following approval (including the former FDA Commissioner), many consider these studies to be equivalent to industry-sponsored research.

Of the 74 aspartame industry-sponsored studies, all 74 (100%) claimed that no problems were found with aspartame. This is reminiscent of tobacco industry research where it is primarily the tobacco research which never finds problems with the product, but nearly all of the independent studies do find problems.

The 74 aspartame industry-sponsored studies are those which one inveriably sees cited in PR/news reports and reported by organizations funded by Monsanto/Benevia/NutraSweet (e.g., IFIC, ADA). These studies have severe design deficiencies which help to guarantee the "desired" outcomes. These design deficiencies may not be apparent to the inexperienced scientist. Healthcare practitioners and scientists should print out the all of the documents on the Monsanto/NutraSweet Scientific Abuse web page, the Scientific FAQs web page and the Aspartame Toxicity Reaction Report Samples. Please refer scientific questions to

Return to: Aspartame ( NutraSweet ) Toxicity Information Center Main Page.